-
Topics:
SABPA OCLA 2015 Biomedical Forum
-
Date/Time:
25 April 2015 - 25 April 2015 @ 8:30 am --- 4:30 pm
-
Location:
Wyndham-Irvine, 17941 Von Karman Avenue, Irvine, CA 92614
-
Attachment:
-
Share:
KEYNOTE SPEAKER
Henry Ji, Ph.D.
Co-founder, CEO and President, Sorrento Therapeutics, Inc.
The mission of this forum is to provide attractive platform for entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences, biotechnology, and alliances across the biomedical industry in Southern California and Pacific Asia. The annual biomedical forum is one of the flagship events organized by SABPA, which have attracted more than 200 attendees, over 20 event sponsors in the past two years. The upcoming annual biomedical forum will focus on the following subjects: (1) Latest innovations in pharmaceutical products, medical devices and nutraceuticals; (2) FDA regulations/enforcements concerning medical and pharmaceutical products; (3) Legal concerns in the developments of pharmaceutical products and medical devices.
Time: April 25th, 2015 (Saturday) 8:30 am --- 4:30 pm
Location: Wyndham-Irvine, 17941 Von Karman Avenue, Irvine, CA 92614
a:15:{i:0;a:3:{s:12:"time_program";s:19:"8:30 am – 8:40 am";s:19:"description_program";s:53:"Jinsong Ni, Ph.D.
President, SABPA OC/LA Chapter";s:7:"program";s:7:"Welcome";}i:1;a:3:{s:12:"time_program";s:19:"8:40 am – 8:50 am";s:19:"description_program";s:122:"Xianzhi Lu
Consul, Science & Technology Office, Consulate General of the People’s Republic of China in Los Angeles";s:7:"program";s:15:"Opening Remarks";}i:2;a:3:{s:12:"time_program";s:19:"8:50 am – 9:00 am";s:19:"description_program";s:59:"Steven Choi, Ph.D.
Mayor of City of Irvine, California";s:7:"program";s:15:"Opening Remarks";}i:3;a:3:{s:12:"time_program";s:19:"9:00 am – 9:45 am";s:19:"description_program";s:201:"Henry Ji, Ph.D. (Keynote Speaker)
Co-founder, CEO and President Sorrento Therapeutics, Inc.
Moderator for Morning Session
Yanbo Yang, Ph.D. CEO and President, BioPharmaDev, Inc. ";s:7:"program";s:60:"Building of a BioPharmaceutical Company - The Sorrento Story";}i:4;a:3:{s:12:"time_program";s:20:"9:45 am – 10:30 am";s:19:"description_program";s:0:"";s:7:"program";s:6:"Break ";}i:5;a:3:{s:12:"time_program";s:21:"10:30 am – 11:00 am";s:19:"description_program";s:55:"Andrew Wang, Ph.D.
President, Ocean NanoTech, LLC ";s:7:"program";s:85:"Nano Particle Related Technology and Its Application in Diagnostics and Drug Delivery";}i:6;a:3:{s:12:"time_program";s:21:"11:00 am – 11:30 am";s:19:"description_program";s:69:"Xingzhe Ding, Ph.D.
Chief Technology Officer, Vitang Technology ";s:7:"program";s:41:"Application of 3D Technology in Dentistry";}i:7;a:3:{s:12:"time_program";s:20:"11:30 am – 1:00 pm";s:19:"description_program";s:138:"Moderator for Afternoon Session
Huaina Li, Ph.D., DABT
Manager, Analytical Technologies of Pharma R&D, B. Braun Medical, Inc. ";s:7:"program";s:7:"Lunch ";}i:8;a:3:{s:12:"time_program";s:19:"1:00 pm – 1:30 pm";s:19:"description_program";s:66:"Tanushree Bose, Ph.D.
Director, Clinical Research, Metagenics";s:7:"program";s:45:"Medical Nutrition Therapy and Glucose Control";}i:9;a:3:{s:12:"time_program";s:19:"1:30 pm – 2:00 pm";s:19:"description_program";s:125:"Mahtab Jafari, Ph.D.
Professor and Director
Department of Pharmaceutical Sciences, University of California, Irvine";s:7:"program";s:43:"Anti-aging Properties of Botanical Extracts";}i:10;a:3:{s:12:"time_program";s:19:"2:00 pm – 2:30 pm";s:19:"description_program";s:81:"Dan R. Solis
Director, Import Operations
Los Angeles District of US FDA";s:7:"program";s:97:"Import/export Challenges and Guidance for Pharmaceutical, Medical Device, and Dietary Supplements";}i:11;a:3:{s:12:"time_program";s:19:"2:30 pm – 3:15 pm";s:19:"description_program";s:16:"China Connection";s:7:"program";s:6:"Break ";}i:12;a:3:{s:12:"time_program";s:20:"3:15 pm – 3:45 pm";s:19:"description_program";s:47:"Frank Zeng
Partner, Dinova Venture Capital";s:7:"program";s:65:"Investment in Medical Technology in China, Prospects and Strategy";}i:13;a:3:{s:12:"time_program";s:20:"3:45 pm – 4:15 pm";s:19:"description_program";s:219:"Joon Woon Chong
Vice President, Strategic Planning & Investment Promotion, Business Development & Commercial, Sembcorp Development, the Singapore shareholder of The Singapore-Sichuan Hi-Tech Innovation Park (SSCIP)";s:7:"program";s:107:"Harnessing Cross-border Synergies: an Opportunity to Leverage the China – Singapore Biomedical Ecosystems";}i:14;a:3:{s:12:"time_program";s:7:"4:15 pm";s:19:"description_program";s:0:"";s:7:"program";s:7:"Closing";}}
President, SABPA OC/LA Chapter";s:7:"program";s:7:"Welcome";}i:1;a:3:{s:12:"time_program";s:19:"8:40 am – 8:50 am";s:19:"description_program";s:122:"Xianzhi Lu
Consul, Science & Technology Office, Consulate General of the People’s Republic of China in Los Angeles";s:7:"program";s:15:"Opening Remarks";}i:2;a:3:{s:12:"time_program";s:19:"8:50 am – 9:00 am";s:19:"description_program";s:59:"Steven Choi, Ph.D.
Mayor of City of Irvine, California";s:7:"program";s:15:"Opening Remarks";}i:3;a:3:{s:12:"time_program";s:19:"9:00 am – 9:45 am";s:19:"description_program";s:201:"Henry Ji, Ph.D. (Keynote Speaker)
Co-founder, CEO and President Sorrento Therapeutics, Inc.
Moderator for Morning Session
Yanbo Yang, Ph.D. CEO and President, BioPharmaDev, Inc. ";s:7:"program";s:60:"Building of a BioPharmaceutical Company - The Sorrento Story";}i:4;a:3:{s:12:"time_program";s:20:"9:45 am – 10:30 am";s:19:"description_program";s:0:"";s:7:"program";s:6:"Break ";}i:5;a:3:{s:12:"time_program";s:21:"10:30 am – 11:00 am";s:19:"description_program";s:55:"Andrew Wang, Ph.D.
President, Ocean NanoTech, LLC ";s:7:"program";s:85:"Nano Particle Related Technology and Its Application in Diagnostics and Drug Delivery";}i:6;a:3:{s:12:"time_program";s:21:"11:00 am – 11:30 am";s:19:"description_program";s:69:"Xingzhe Ding, Ph.D.
Chief Technology Officer, Vitang Technology ";s:7:"program";s:41:"Application of 3D Technology in Dentistry";}i:7;a:3:{s:12:"time_program";s:20:"11:30 am – 1:00 pm";s:19:"description_program";s:138:"Moderator for Afternoon Session
Huaina Li, Ph.D., DABT
Manager, Analytical Technologies of Pharma R&D, B. Braun Medical, Inc. ";s:7:"program";s:7:"Lunch ";}i:8;a:3:{s:12:"time_program";s:19:"1:00 pm – 1:30 pm";s:19:"description_program";s:66:"Tanushree Bose, Ph.D.
Director, Clinical Research, Metagenics";s:7:"program";s:45:"Medical Nutrition Therapy and Glucose Control";}i:9;a:3:{s:12:"time_program";s:19:"1:30 pm – 2:00 pm";s:19:"description_program";s:125:"Mahtab Jafari, Ph.D.
Professor and Director
Department of Pharmaceutical Sciences, University of California, Irvine";s:7:"program";s:43:"Anti-aging Properties of Botanical Extracts";}i:10;a:3:{s:12:"time_program";s:19:"2:00 pm – 2:30 pm";s:19:"description_program";s:81:"Dan R. Solis
Director, Import Operations
Los Angeles District of US FDA";s:7:"program";s:97:"Import/export Challenges and Guidance for Pharmaceutical, Medical Device, and Dietary Supplements";}i:11;a:3:{s:12:"time_program";s:19:"2:30 pm – 3:15 pm";s:19:"description_program";s:16:"China Connection";s:7:"program";s:6:"Break ";}i:12;a:3:{s:12:"time_program";s:20:"3:15 pm – 3:45 pm";s:19:"description_program";s:47:"Frank Zeng
Partner, Dinova Venture Capital";s:7:"program";s:65:"Investment in Medical Technology in China, Prospects and Strategy";}i:13;a:3:{s:12:"time_program";s:20:"3:45 pm – 4:15 pm";s:19:"description_program";s:219:"Joon Woon Chong
Vice President, Strategic Planning & Investment Promotion, Business Development & Commercial, Sembcorp Development, the Singapore shareholder of The Singapore-Sichuan Hi-Tech Innovation Park (SSCIP)";s:7:"program";s:107:"Harnessing Cross-border Synergies: an Opportunity to Leverage the China – Singapore Biomedical Ecosystems";}i:14;a:3:{s:12:"time_program";s:7:"4:15 pm";s:19:"description_program";s:0:"";s:7:"program";s:7:"Closing";}}
Thanks for your interest in attending our event. Due to the limited capacity of the venue, this event is closed to further registrations. Please check back for more exciting events organized by SABPA OCLA.
Please contact us if you have any questions.
SABPA OCLA
